Catalog #: FAFT200
For in vitro diagnostic use
Direct EIA (enzyme immunoassay) test kit for the detection and measurement of activated factor XII.
Kit Components
Specimen Collection and Storage
Venipuncture should be clean and deliberate to avoid activation of coagulation.
Collect blood in 0.109M trisodium citrate anticoagulant, using the ratio 1 volume of anticoagulant to 9 volumes of blood. The use of other anticoagulants has not been validated.
Whole blood should be centrifuged at 3000 x g for 10 minutes. Plasma must be separated within 1 hour of sample collection.
Do not store samples at 2-8°C as this may initiate cold activation in some samples. Plasma samples can be stored for up to three hours at room temperature prior to assay.
Expected Values
|
MEAN |
|
|
'Normal' |
1.53 ng/ml |
|
Diabetes |
9.52 ng/ml |
|
Renal failure |
10.06 ng/ml |
|
Coronary artery disease |
3.05 ng/ml |
|
Thrombolysis |
11.22 ng/ml |
(references available on request)
Imprecision
|
Within assay imprecision |
|||
|
Control |
Mean Conc. ng/ml |
Root Mean Square CV% |
n |
|
1 |
1.60 |
4.9% |
20 |
|
2 |
3.21 |
4.49% |
20 |
|
3 |
8.42 |
2.98% |
20 |
|
4 |
10.4 |
3.86% |
20 |
|
Between-assay imprecision |
||||
|
Control |
Conc. ng/ml |
SD |
CV% |
n |
|
1 |
1.60 |
0.176 |
11.0% |
20 |
|
2 |
3.21 |
0.173 |
5.39% |
20 |
|
3 |
8.42 |
0.462 |
5.49% |
20 |
|
4 |
10.4 |
0.539 |
5.18% |
20 |
Summary of the Protocol
| Name | Type | Size |
|---|---|---|
| Afecta Certificate of Product Conformance 05264902 | application/pdf | 2.07 MB |
| Afecta Flyer 1 | application/pdf | 17.53 kB |
| Afecta Flyer 2 | application/pdf | 41.59 kB |